Japan Asset Strategy Leader, Immunology, R&D
AbbVie seeks a Japan Asset Strategy Leader in Immunology to drive impactful medicine development and strategy for Japan. The role emphasizes creating competitive asset strategies, leading cross-functional teams, and ensuring alignment with global strategy. The ideal candidate will possess extensive clinical development experience, particularly in new drug applications. This position involves collaboration with various stakeholders and requires robust knowledge of drug development processes, therapeutic areas, and effective communication skills in both Japanese and English.
Job description
Purpose Statement:
Bring impactful medicines to patients as quickly and efficiently as possible, working as one with global teams to deliver the most competitive asset strategies
Responsibilities:
- Defines and executes a development strategy for Japan for individual asset programs which contributes to sustainable, successful growth of AbbVie GK
- Ensures that the individual development assets add significant value to AbbVie GK, through effective, rapid and broad development of pipeline assets, with adequate consideration of market access, medical and commercialization aspects
- Takes a holistic and strategic approach to maximize performance of Japan Asset Strategy Teams by leading, driving and coordinating all development activities for Japan
- Foster continuous improvement mindset as one team from learnings throughout asset lifecycle
Role:
Develop an integrated development strategy for Japan
- Creates the most competitive strategy based on regulatory requirements and commercial needs
- Brings new products to the market through fastest and cost-optimized approach
- Provides inputs to Asset Strategy Team (AST) ensuring Japan development strategy is integrated into the global development strategy
- Ensures alignment on the program development strategies within Japan Asset Strategy Team (JAST) and with relevant stakeholders including governance bodies in Japan (e.g. Therapeutic Area Review Meeting, Japan NPI) and AST
- Represents JAST at ASTs and the appropriate decision bodies in Japan
Lead the Japan Asset Strategy Team
- Sets challenging individual asset-related objectives for and together with cross-functional team members to be considered in team member’s objective setting
- Fosters trust and transparency within the cross-functional team and works to maximize engagement to optimize team functioning
- For asset-related activities, provides regular feedback and coaching to team member concerning their contribution to the team performance and target objectives
Is accountable for advancing assets on time, in (external) budget and required quality
- Defines and plans development timelines and milestones in alignment with JAST members, key bodies in Japan and AST
- Drives and steers the implementation of the asset strategy in Japan, by leading JASTs and cooperating with ASTs
- Proactively develops proposals to manage/mitigate/resolve risks for a project in Japan
- Holds JAST members responsible for committed timelines and budgets in Japan
For Grade 18 JASL:
- Leads large, complex, highly visible, multi-indication asset and/or a suite of assets across multiple stages of development or franchise
- Able to actively influence, shape and drive cross-functional decision-making of high priority, complex programs
- Build strong connections to the global Asset Strategy Leadership group, proactively influencing global development strategy from affiliate perspective
- Represents excellence in Japan Asset Leadership. Coaches and mentors less experienced JASLs
Expected hiring grade:
- 17 or 18 (Offering position will be determined based on the career experience and evaluation)
Background/Experience:
At least 5 years in clinical development and experience of one or more NDAs, or equivalent knowledge. Development experience for assigned multiple therapeutic areas, or equivalent knowledge.
Education:
Graduate from Medical School, College of Nursing, College of Pharmacy, College of Science/Agriculture, or life-science course (Holder of master degree or PhD degree is preferable), or equivalent education Preferred, holder of Medical Doctor, Veterinarian, Pharmacist, or other related with life-science related degree or license
Leadership Behavior/Mindset:
- Set Vision
- Anticipate
- Innovate
- Build
- Deliver Results
Knowledge:
Sufficient knowledge regarding process of NDA and approval from making clinical development plan (PMDA consultation, Protocol preparation, Study management, CTD preparation, response to PMDA queries after NDA etc.) Sufficient knowledge in the therapeutic area assigned General knowledge of pharmaceutical association (Seiyaku kyo and Pharma etc.) The latest guidelines and regulations (GCP etc.) TOEIC score is 850 or higher, or equivalent skill for English communication.
Skill:
- Leadership
- Coaching
- Team building
- Communication skill with both of Japanese and English
- Facilitation Skill
アッヴィは、機会均等を重視する雇用主であり、誠実な企業活動、革新の推進、人々の生活への貢献、そして地域社会への貢献に努めています。
Job details
- Published
- March 11, 2026
- Last checked
- June 25, 2026
- Job source
- smartrecruiters
- Workplace
- On-site · 港区, JP
- First seen
- March 11, 2026
See how well you match this job
Log in or sign up and Eva will compare your profile with this role, explain your strengths and show what to improve.
Sign up to see your matchAlready have an account? Log inMore at AbbVie
Similar jobs from this company
None listed.
Across the market
Similar jobs from other companies
Third-party content disclaimer
Full job descriptions are sourced directly from third-party applicant tracking systems (ATS), job boards, recruitment platforms, and employer career pages.
LiftmyCV does not claim ownership of this content or guarantee its accuracy or current availability. All original content is the intellectual property of the respective employers or other rights holders.
LiftmyCV hiring intelligence, availability checks, and related-job recommendations are generated from LiftmyCV data and public sources.
If you prefer, you may apply directly via the original listing for transparency.